World journal of urology
Journal
Overview
publication venue for
-
Gender inequality in genitourinary malignancies clinical trials leadership..
42.
2024
-
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA..
41.
2023
-
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer..
41.
2023
-
Preoperative stricture length measurement does not predict postoperative outcomes in robotic ureteral reconstructive surgery.
2023
-
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma..
41.
2023
-
Characterization of the histological response to the Butterfly Prostatic Retraction Device in patients with benign prostatic hyperplasia.
2023
-
Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study.
2022
-
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis..
41.
2022
-
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity..
40.
2022
-
Development of a North American coordinated registry network for surgical treatment of benign prostatic hyperplasia.
2022
-
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)..
40.
2022
-
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registry..
40.
2022
-
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer..
40.
2022
-
External validation of two mpMRI-risk calculators predicting risk of prostate cancer before biopsy..
40.
2022
-
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis..
41.
2022
-
Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study..
40.
2022
-
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer..
40.
2022
-
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
2022
-
Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer.
2022
-
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer.
2022
-
Real-world data comparing minimally invasive surgeries for benign prostatic hyperplasia.
2022
-
Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients.
2022
-
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.
2021
-
Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach.
2021
-
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy..
40.
2021
-
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer..
39.
2021
-
Safety and efficacy of TURP vs. laser prostatectomy for the treatment of benign prostatic hyperplasia in multi-morbid and elderly individuals aged ≥ 75.
2021
-
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival..
39.
2021
-
Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer..
39.
2021
-
Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy..
39.
2021
-
Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities..
39.
2021
-
Frailty as predictor of complications in patients undergoing percutaneous nephrolithotomy (PCNL).
2021
-
Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer..
39.
2021
-
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors..
39.
2021
-
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer..
39.
2021
-
Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones..
39.
2020
-
Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)..
39.
2020
-
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent..
39.
2020
-
The association between plant-based content in diet and testosterone levels in US adults..
39.
2020
-
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study..
39.
2020
-
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration..
39.
2020
-
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis..
39.
2020
-
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder..
38.
2020
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer..
38.
2019
-
Dependence of laser-induced tissue ablation on optical fiber movements for laser prostatectomy..
38.
2019
-
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases..
38.
2019
-
Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients..
38.
2019
-
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis..
38.
2019
-
Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality..
38.
2019
-
Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization..
38.
2019
-
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor..
38.
2019
-
Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer..
37.
2019
-
Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy..
37.
2019
-
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study..
37.
2019
-
Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology..
37.
2019
-
Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma..
37.
2018
-
Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United States..
37.
2018
-
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract..
37.
2018
-
The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer..
37.
2018
-
Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy..
36.
2018
-
Unintended consequences of decreased PSA-based prostate cancer screening..
37.
2018
-
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer..
37.
2018
-
Cost analysis of prostate cancer detection including the prostate health index (phi)..
37.
2018
-
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy..
37.
2018
-
Salvage topical therapy for upper tract urothelial carcinoma..
36.
2018
-
Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought..
36.
2018
-
Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer..
36.
2018
-
Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study..
36.
2018
-
Role of quantitative computed tomography texture analysis in the prediction of adherent perinephric fat..
36.
2018
-
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomy..
36.
2018
-
Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer..
36.
2018
-
Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy..
36.
2018
-
Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder..
36.
2017
-
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis..
36.
2017
-
Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy..
36.
2017
-
Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1-2 N0 M0 renal cell carcinoma..
35.
2017
-
Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients..
35.
2017
-
Minimally invasive vs open nephrectomy in the modern era: does approach matter?.
35.
2017
-
Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy..
35.
2017
-
The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy..
35.
2016
-
Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study..
35.
2016
-
Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer..
35.
2016
-
Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract..
35.
2016
-
Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms..
35.
2016
-
Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation..
35.
2016
-
A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients..
35.
2016
-
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)..
35.
2016
-
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy..
35.
2016
-
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study..
35.
2016
-
Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically..
35.
2016
-
Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution..
34.
2016
-
Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma..
34.
2016
-
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma..
34.
2016
-
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent..
34.
2015
-
Low yield of surveillance imaging after surgery for T1 kidney cancer..
34.
2015
-
Multiparametric MRI of the prostate at 3 T: limited value of 3D (1)H-MR spectroscopy as a fourth parameter..
34.
2015
-
Construct, content and face validity of the camera handling trainer (CHT): a new E-BLUS training task for 30° laparoscope navigation skills..
34.
2015
-
Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically..
34.
2015
-
Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?.
34.
2015
-
Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics..
33.
2015
-
TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma..
33.
2015
-
Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta..
33.
2015
-
Partial nephrectomy driven by cavitron ultrasonic surgical aspirator under zero ischemia: a pilot study..
33.
2015
-
Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma..
33.
2015
-
Histopathology and prognosis of de novo bladder tumors following solid organ transplantation..
33.
2015
-
The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy..
33.
2015
-
Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?.
33.
2014
-
Postoperative complications and short-term oncological outcomes of patients aged ≥80 years undergoing robot-assisted radical cystectomy..
33.
2014
-
Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy..
33.
2014
-
Insignificant disease among men with intermediate-risk prostate cancer..
32.
2014
-
Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems..
33.
2014
-
Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study..
33.
2014
-
Impact of warm versus cold ischemia on renal function following partial nephrectomy..
33.
2014
-
Lower urinary tract symptoms in patients with liver cirrhosis..
33.
2014
-
Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions..
33.
2014
-
Diagnosis of renal tumors by in vivo proton magnetic resonance spectroscopy..
33.
2014
-
Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer..
33.
2014
-
Single-Incision Transumbilical Surgery (SITUS) versus Single-Port Laparoscopic Surgery and conventional laparoscopic surgery: a prospective randomized comparative study of performance with novices in a dry laboratory..
33.
2014
-
Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample..
32.
2014
-
Analysis of lymph node dissection in patients with ≥7-cm renal tumors..
32.
2014
-
Non-squamous cell carcinoma of the penis: single-center, 15-year experience..
32.
2013
-
Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study..
32.
2013
-
Assessment of the learning curves for photoselective vaporization of the prostate using GreenLight™ 180-Watt-XPS laser therapy: defining the intra-operative parameters within a prospective cohort..
32.
2013
-
Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer..
32.
2013
-
Urodynamic characterization of lower urinary tract symptoms in men less than 40 years of age..
32.
2013
-
Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses..
32.
2013
-
The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer..
32.
2013
-
The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy..
32.
2013
-
Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL..
32.
2013
-
Use of the Bulbocavernosus Reflex System in assessing voiding dysfunction..
31.
2013
-
Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing..
31.
2013
-
Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder..
31.
2012
-
Effect of minimizing tension during robotic-assisted laparoscopic radical prostatectomy on urinary function recovery..
31.
2012
-
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer..
30.
2012
-
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma..
31.
2012
-
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?.
30.
2012
-
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group..
32.
2012
-
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group..
30.
2011
-
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group..
30.
2011
-
Predicting prostate cancer many years before diagnosis: how and why?.
30.
2011
-
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy..
30.
2011
-
Does partial nephrectomy at an academic institution result in better outcomes?.
30.
2011
-
Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder..
30.
2011
-
No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study..
29.
2011
-
Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy..
31.
2011
-
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients..
29.
2011
-
Nerve-sparing technique and urinary control after robot-assisted laparoscopic prostatectomy..
29.
2010
-
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma..
29.
2010
-
Application of new technology in bladder cancer diagnosis and treatment..
27.
2009
-
From proficiency to expert, when does the learning curve for robotic-assisted prostatectomies plateau? The Columbia University experience..
25.
2007
-
Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer..
22.
2004
-
Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities..
13.
1995
-
Intravesical therapy for bladder cancer in the pandemic of Covid-19..
39.
2020
-
Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept.
2020
-
ICUD guidelines for upper tract urothelial carcinoma: a state-of-the-art evidence-based guidance for clinical decisions regarding diagnosis, management and treatment..
35.
2017
-
Urothelial carcinoma..
29.
2011
-
Challenges in testicular cancer management..
27.
2009
-
Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis.
2019
-
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer.
2018
-
Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
2018
-
Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.
2017
-
Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
2017
-
Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?
2016
-
Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.
2016
-
Innovations in diagnostic imaging of localized prostate cancer.
2014
-
The survival benefit of lymph node dissection at the time of removal of kidney, prostate and urothelial carcinomas: what is the evidence?
2013
-
Impact of gender on bladder cancer incidence, staging, and prognosis.
2011
-
Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy.
2011
-
Health services research in urology.
2011
-
Good-risk-advanced germ cell tumors: historical perspective and current standards of care.
2009
-
En bloc resection of bladder tumour: the rebirth of past through reminiscence.
2023
-
Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review and network meta-analysis of oncologic outcomes.
2023
-
Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis.
2023
-
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.
2022
-
MRI as a screening tool for prostate cancer: current evidence and future challenges.
2022
-
Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis.
2021
-
The evolution and resurgence of perineal prostatectomy in the robotic surgical era.
2019
-
New drugs and new approaches for the treatment of metastatic urothelial cancer.
2002
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)